Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Fiserv, Inc. (NASDAQ:FISV)?

Fiserv, Inc. (NASDAQ:FISV) investors should be aware of a decrease in activity from the world’s largest hedge funds lately.

Fiserv, Inc. (NASDAQ:FISV)

In today’s marketplace, there are many methods market participants can use to track publicly traded companies. A duo of the most innovative are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite investment managers can beat the broader indices by a superb margin (see just how much).

Equally as important, bullish insider trading activity is another way to break down the marketplace. Obviously, there are many incentives for a corporate insider to get rid of shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Many academic studies have demonstrated the market-beating potential of this tactic if you know where to look (learn more here).

Consequently, let’s take a look at the key action regarding Fiserv, Inc. (NASDAQ:FISV).

What have hedge funds been doing with Fiserv, Inc. (NASDAQ:FISV)?

In preparation for this year, a total of 18 of the hedge funds we track were bullish in this stock, a change of -5% from one quarter earlier. With hedgies’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were increasing their stakes substantially.

When looking at the hedgies we track, Egerton Capital Limited, managed by John Armitage, holds the most valuable position in Fiserv, Inc. (NASDAQ:FISV). Egerton Capital Limited has a $135 million position in the stock, comprising 5% of its 13F portfolio. Coming in second is Brave Warrior Capital, managed by Glenn Greenberg, which held a $112 million position; 0% of its 13F portfolio is allocated to the company. Remaining hedgies that hold long positions include Ricky Sandler’s Eminence Capital, Lou Simpson’s SQ Advisors and Steven Richman’s East Side Capital (RR Partners).

Due to the fact that Fiserv, Inc. (NASDAQ:FISV) has witnessed bearish sentiment from hedge fund managers, logic holds that there were a few hedge funds that elected to cut their positions entirely last quarter. Interestingly, Ken Gray and Steve Walsh’s Bryn Mawr Capital dumped the largest position of the 450+ funds we track, comprising about $6 million in stock.. Anand Parekh’s fund, Alyeska Investment Group, also dropped its stock, about $1 million worth. These transactions are intriguing to say the least, as total hedge fund interest fell by 1 funds last quarter.

How are insiders trading Fiserv, Inc. (NASDAQ:FISV)?

Insider trading activity, especially when it’s bullish, is particularly usable when the primary stock in question has seen transactions within the past six months. Over the last six-month time period, Fiserv, Inc. (NASDAQ:FISV) has seen zero unique insiders buying, and 5 insider sales (see the details of insider trades here).

With the results demonstrated by our time-tested strategies, retail investors should always watch hedge fund and insider trading activity, and Fiserv, Inc. (NASDAQ:FISV) is an important part of this process.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!